IPF Insights

The Impact of the 2018 Diagnostic Guidelines on Clinical Outcomes in IPF

As clinicians, we are keenly aware that guidelines on the diagnosis and treatment of a disease change, as continuous research provides additional clarity and information. In the UK, this is perhaps most poignantly reflected in the British National Formulary, which is essentially a book on the latest British guidelines for drug prescription. The book is…

IPF prognosis

Prognosis in IPF Remains Poor Amid a Lack of Consensus on Treatment Approach

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease of unknown origin. Interstitial lung disease in itself is an umbrella term for various diseases that cause inflammation, cellular proliferation, and fibrosis of lung tissue. The fibrosis of the lung replaces healthy tissue with a modified extracellular matrix that deeply damages it.  There is much we…

IPF complications

Demystifying Idiopathic Pulmonary Fibrosis

Whenever we hear a disease labeled “idiopathic,” there is a good chance science just hasn’t caught up to understanding its full etiology. For example, silicosis, a disease thought to be “idiopathic” when first identified, is now conclusively linked to the inhalation of microscopic crystalline silica dust, which is an occupational hazard in the construction and…

Next post in Insights